Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Biomedicines|July 19, 2020
Intrinsic Type 1 Interferon (IFN1) Profile of Uncultured Human Bone Marrow CD45lowCD271+ Multipotential Stromal Cells (BM-MSCs): The Impact of Donor Age, Culture Expansion and IFNα and IFNβ StimulationPayal Ganguly, Agata N Burska, Charlotte L M Davis, et al.
Clinical and Experimental Rheumatology|July 15, 2020
Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis?Frederique Ponchel, Myrthe A M van Delft, Xuanxiao Xie, et al.
Scientific Reports|March 1, 2020
T-cell subset abnormalities predict progression along the Inflammatory Arthritis disease continuum: implications for managementFrederique Ponchel, Agata N Burska, Laura Hunt, et al.
Scientific Reports|June 29, 2019
Gene expression and functional comparison between multipotential stromal cells from lateral and medial condyles of knee osteoarthritis patientsClara Sanjurjo-Rodriguez, Thomas G Baboolal, Agata N Burska, et al.
Arthritis Research & Therapy|December 24, 2014
Modulation of peripheral T-cell function by interleukin-7 in rheumatoid arthritisSarah M Churchman, Jehan J El-Jawhari, Agata N Burska, et al.
Rheumatology (Oxford, England)|May 14, 2019
Quantifying circulating Th17 cells by qPCR: potential as diagnostic biomarker for rheumatoid arthritisAgata N Burska, Aye Thu, Rekha Parmar, et al.
Mediators of Inflammation|May 1, 2014
Autoantibodies to posttranslational modifications in rheumatoid arthritisAgata N Burska, Laura Hunt, Marjorie Boissinot, et al.
Clinical and Experimental Rheumatology|October 6, 2017
Serum IL-7 as diagnostic biomarker for rheumatoid arthritis, validation with EULAR 2010 classification criteriaAgata N Burska, Jessica Neilan, Ruth E Chisman, et al.
International Journal of Molecular Sciences|March 13, 2024
The Vitamin C Enantiomers Possess a Comparable Potency in the Induction of Oxidative Stress in Cancer Cells but Differ in Their ToxicityDinara Begimbetova, Agata N Burska, Aidana Baltabekova, et al.
Clinical and Experimental Rheumatology|August 24, 2020
Receptor activator of nuclear factor kappa-Β ligand (RANKL) serum levels are associated with progression to seropositive/negative rheumatoid arthritisAgata N Burska, Jehan J El-Jawhari, Jianhua Wu, et al.
Pageof 3